Dexcom has just launched Stelo, its first over-the-counter continuous glucose monitor (CGM) available for purchase in the U.S. This innovative device, aimed at individuals with prediabetes or Type 2 diabetes who aren’t insulin-dependent, offers a new way for users to monitor their glucose levels without a prescription. While Dexcom is known for its CGMs for Type 1 and Type 2 diabetes patients, Stelo represents the company’s entry into the broader and increasingly relevant prediabetes market.
Stelo is designed not just as a monitoring tool but as a guide to help users understand how their diet and lifestyle choices impact their glucose levels. Available for $99 per month, or $89 with a subscription, the device offers flexibility in payment options, including the use of Flexible Spending Accounts and Health Savings Accounts. What sets Stelo apart is its accessibility—it’s designed to empower the 125 million Americans living with prediabetes or Type 2 diabetes who are not using insulin to take control of their health.
Once set up, the sensor wirelessly transmits data to the Stelo smartphone app, which updates every 15 minutes. The app allows users to monitor their glucose levels, track patterns, and make informed decisions about their health. Stelo’s user-friendly design includes a "Learn" tab with educational materials that break down complex topics into digestible content, helping users understand the importance of maintaining glucose levels within a healthy range.
Stelo also stands out for its ease of use. The monitor is small, comfortable, and can be worn on the upper arm for up to 15 days. It’s waterproof and can be worn during various activities, with minimal intrusion into daily life. The app’s interface is straightforward, with features that allow users to log meals, activities, and even sync with health data from other apps like Apple Health or Android's Health Connect.
In the competitive landscape of CGMs, Stelo is a game-changer. It not only fills a gap in the market by catering to those without severe diabetes but also serves as a tool for anyone interested in gaining insights into their glucose levels. Dexcom’s strategic move into this segment could significantly impact how individuals manage their health, providing them with a powerful, accessible tool to better understand and control their glucose levels.
